OPTIMIZE SYSTEMS INC
Domain name marketplace and registration platform
- Sector
- Digital health
- Headquarters
- SEATTLE, WA
- Founded
- 2015
- Latest Form D
- $6M, May 2023
- Total capital
- $23.7M
- Federal grants
- $235K
- 1 award · 2019
- Sector median 0 awards
- Private capital raised
- $23.4M
- 5 Form D · last May 2023
- 41 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$6M
- Private capital raisedForm D · SEC · 4th filing$2M
- Private capital raisedForm D · SEC · 3rd filing$15M
- Federal grantHealth and Human S · Phase II · Connected Pharmacy Platform to Improve Adherence to Buprenorphine-Naloxone Prescription Treatment of Opioid Use Disorder$235K
- Private capital raisedForm D · SEC · 2nd filing$425K
- Private capital raisedForm D · SEC · 1st filing$20K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Jeffrey LebrunResearcherDirectorLinked by $235K in grants as PI
- Chukwuma OnwunemeExecutive Officer, DirectorNamed in SEC Form D filings
- Jeff LeBrunExecutive Officer, DirectorNamed in SEC Form D filings
- Jennifer RichardDirectorNamed in SEC Form D filings
- Jim AndelmanDirectorNamed in SEC Form D filings
- Lindel EakmanDirectorNamed in SEC Form D filings
Show all 7 people
- Todd HaedrichExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 1- PendingSystem, Methods, & Device For Managing A ProductUSPTOApplication 16727604
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .